Stay updated with breaking news from Narcolepsy Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
30.03.2022 - – Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming clinical milestones – – SerpinPC registration studies planned to begin in 2H 2022 following recent FDA meeting; initial focus on ...
9:00 p.m. – 9:05 p.m. Introduction 8:05 a.m. – 8:10 a.m. 9:05 p.m. – 9:10 p.m. Delivering an Innovative Pipeline to Our Patients: Spotlight on Select Wave 1 Programs Andy Plump, president of Research and Development 8:10 a.m. – 8:35 a.m. 9:10 p.m. – 9:35 p.m. Maribavir (TAK-620): Potential Game Changer in the Treatment for Post-Transplant Cytomegalovirus (CMV) Infection Obi Umeh, global program lead, Rare Genetic and Hematology Therapeutic Area Unit Claus Jepsen, head of Global Product and Launch Strategy, Rare Genetic and Hematology Therapeutic Area Unit 8:35 a.m. – 8:40a.m. ...